Joseph K. Han, MD, FARS, FAAAAI - Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!
Christine Franzese, MD, FARS, Flavia C.L. Hoyte, MD, FACAAI - The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments
Bhavana Pothuri, MD, MS - Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastSara M. Tinsley, PhD, APRN, AOCN - Therapeutic Advancements in Myelodysplastic Syndromes: Bridging the Gap Between Patient Safety and Quality Care Through the Latest Science and Evidence-Based Learnin
PeerView Internal Medicine CME/CNE/CPE Audio PodcastBradley J. Monk, MD, FACS, FACOG - When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastRichard S. Finn, MD - Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast